Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 242.02M P/E - EPS this Y 138.30% Ern Qtrly Grth -
Income -16.05M Forward P/E 28.80 EPS next Y 352.20% 50D Avg Chg 1.00%
Sales 21.25M PEG - EPS past 5Y - 200D Avg Chg -2.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -20.00%
Recommedations 1.80 Quick Ratio 2.92 Shares Outstanding 27.10M 52W Low Chg 39.00%
Insider Own 14.60% ROA -29.67% Shares Float 15.29M Beta 0.40
Inst Own 55.25% ROE - Shares Shorted/Prior 1.87M/1.69M Price 8.64
Gross Margin 94.08% Profit Margin -75.50% Avg. Volume 124,624 Target Price 18.33
Oper. Margin -18.68% Earnings Date May 9 Volume 34,264 Change -1.26%
About Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Fennec Pharmaceuticals Inc. News
04/09/24 Those who invested in Fennec Pharmaceuticals (NASDAQ:FENC) five years ago are up 136%
04/05/24 Insider Sell: CEO Rosty Raykov Sells 88,583 Shares of Fennec Pharmaceuticals Inc (FENC)
03/27/24 Chief Financial Officer Robert Andrade Sells 13,975 Shares of Fennec Pharmaceuticals Inc (FENC)
03/26/24 Chief Financial Officer Robert Andrade Sells Shares of Fennec Pharmaceuticals Inc (FENC)
03/22/24 Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2023 Earnings Call Transcript
03/22/24 Q4 2023 Fennec Pharmaceuticals Inc Earnings Call
03/21/24 Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
03/19/24 Fennec (FENC) Signs Licensing Deal With Norgine, Stock Up
03/19/24 Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024
03/17/24 Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
03/13/24 Analysts Are Optimistic We'll See A Profit From Fennec Pharmaceuticals Inc. (NASDAQ:FENC)
02/29/24 Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
05:55 AM FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin
01/06/24 Insider Sell: CFO Robert Andrade Sells 30,000 Shares of Fennec Pharmaceuticals Inc
12/06/23 With 31% stake, Fennec Pharmaceuticals Inc. (NASDAQ:FENC) seems to have captured hedge funds investors' interest
12/05/23 Fennec Announces Incremental $5 Million Investment from Petrichor
11/09/23 Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
11/09/23 Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
11/07/23 Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q3 2023 Earnings Call Transcript
11/07/23 Q3 2023 Fennec Pharmaceuticals Inc Earnings Call
FENC Chatroom

User Image Mazen95134 Posted - 04/29/24

$FENC Ask is setting at $9.15 and nobody is buying. The MC of this company is $245M which is less than the so-called European "great" deal. Insiders sold from $11 all the way down to $10.30! There should be a price like the Nobel price for the best CEO of the year. I will nominate Rosty for sure! What a disaster management. $7.5 is next in a few weeks.

User Image jumhoura1 Posted - 04/26/24

$FENC can we sell the company already please 🙏🏻

User Image Mazen95134 Posted - 04/24/24

$FENC Rosty & Robert after the European deal.

User Image Eaglelanded Posted - 04/23/24

$FENC more insider selling? This is criminal

User Image insiderbuyingselling Posted - 04/22/24

$FENC new insider selling: 44445 shares. http://insiderbuyingselling.com/?t=FENC

User Image Mazen95134 Posted - 04/22/24

$FENC Wow!! How many shares this pos COO is unloading? Look at the filing below. Everyday he is selling. So no wonder the sp is going down. He is helping the shorts!!! How many shares Rosty gave this loser? And for which achievement? And where is the SEC? Is this even legal? https://investors.fennecpharma.com/static-files/50696ae0-6200-4063-8b17-7a927f1a7a5e

User Image insiderbuyingselling Posted - 04/18/24

$FENC new insider selling: 88888 shares. http://insiderbuyingselling.com/?t=FENC

User Image Eaglelanded Posted - 04/18/24

$FENC stock always dropping

User Image JackCampbell Posted - 04/17/24

$FENC latest sell 88888 shrs was due to options expiration. He got them at $2.31. This is a usual process.

User Image Mazen95134 Posted - 04/17/24

$FENC There you go again. Adrian is dumping all his shares. is this pos company going down? where are the large shareholders and how do they tolerate this? This is the third form 144 in three days that this loser filed. In a few days, this pos stock will be back to $7.5!!! I wish that i never bought this crap. https://investors.fennecpharma.com/static-files/d4655fd3-1afd-47f1-85a1-12f5b57b09b3

User Image Mazen95134 Posted - 04/17/24

$FENC Are insiders dumping again? Forms 144 will tell the tale soon! What a crook management this pos company has!

User Image JackCampbell Posted - 04/17/24

$FENC patience will pay off. 3 different price target with media $17! Buyout in also in the cards!

User Image Mazen95134 Posted - 04/17/24

$FENC What a pos!!!!

User Image insiderbuyingselling Posted - 04/16/24

$FENC new insider selling: 88888 shares. http://insiderbuyingselling.com/?t=FENC

User Image insiderbuyingselling Posted - 04/15/24

$FENC new insider selling: 800 shares. http://insiderbuyingselling.com/?t=FENC

User Image JackCampbell Posted - 04/12/24

$FENC could be $50+ stock within 2 yrs!

User Image JackCampbell Posted - 04/12/24

$FENC simplywall.st sees a fair value of $209.50! Impressive...

User Image Mazen95134 Posted - 04/09/24

$FENC Good job Rosty! After selling almost one million dollars worse of shares between him and Robert (Dumb & Dumber), he left the shareholders holding the bags. What a low life pos this Rosty is!!! When this nightmare will be over???

User Image insiderbuyingselling Posted - 04/06/24

$FENC new insider selling: 88583 shares. http://insiderbuyingselling.com/?t=FENC

User Image SouthHaus Posted - 04/04/24

$FENC HC Wainwright raises target price to $18.

User Image Night_Owl_Biotech Posted - 04/03/24

$FENC would be worth roughly $23.50 a share if FENC was acquired at the same multiple of 12-year product revenue forecasts as CTIC. The attachment notes the VONJO product revenue & gross margin forecast by year that CTI BioPharma prepared for Sobi when CTI was acquired in Q223. CTI was acquired for an enterprise value of $1.7B which was 27% of the VONJO cumulative 12-year revenue forecast. Using FENC analyst consensus revenue estimates thru FY31 & 5% sales growth assumptions thru FY35, PedMark would generate $2.768B in product sales. Using the 27% CTI multiple would suggest FENC is worth $752MM or ~$23 a share (like @footlsfoot We have no idea if this is an appropriate comparison but the math is the math. All other things being equal, FENC would, in theory, get consideration for a terminal value as PedMark is patented thru 2039 (v. 2033 for VONJO). We could be wrong. The data may be inaccurate. This is not investment advice.

User Image footlsfoot Posted - 04/02/24

$FENC my DCF states this is worth $22, my comp analysis stated $17….

User Image jumhoura1 Posted - 04/02/24

$FENC never been so patient for a 2xer

User Image Doozio Posted - 03/30/24

$FENC moar 🧠⏰ wen? Barrring a faatch 💣

User Image SouthHaus Posted - 03/29/24

$FENC Can you name three Bolt-ons? I’ll start…: Michael Bolt-on…John Bolt-on…FENC. Sell the U. S. rights already!!!

User Image Night_Owl_Biotech Posted - 03/27/24

The attachment lists all ind comm'l-stage bios with FDA approval since 1/1/17 (it may not reflect all 3/24 approvals). The left side notes oncology focused biopharmas. The right side = non-oncology. If we had to guess (that's all it'd be) which are candidates for near-term acquisition, it'd be $SWTX, $FENC, $DCPH, $ITCI & $RARE. SWTX is our pick for a near term buyout. SWTX's CEO is adamant Ogsiveo is a $1B+/year therapy just in the US (suggesting $2B globally) & B of A has ReNeu @ $1.5B in peak sales ($3B+ btwn the 2 products). SWTX may (again may) be worth more than IMGN because: 1. SWTX peak sales could be higher ($3B+ for SWTX per the experts v. $2.7B per IMGN) 2. Patents run 7 years longer (both SWTX products are patented thru 2043 where IMGN sales peak in 2036 per their 14A) 3. SWTX has 2 products to IMGN's 1 4. Both sell pills so gross margins should be the same Of course we could be wrong. We only suggest researching SWTX for yourself. Good luck.

User Image insiderbuyingselling Posted - 03/27/24

$FENC new insider selling: 2114 shares. http://insiderbuyingselling.com/?t=FENC

User Image InsiderPeek Posted - 03/27/24

$FENC CFO Andrade Robert sold 14k shares for $152.3k (ownership down 13.22%) insiderpeek.com/company/FENC

User Image insiderbuyingselling Posted - 03/25/24

$FENC new insider selling: 13975 shares. http://insiderbuyingselling.com/?t=FENC

User Image Eaglelanded Posted - 03/22/24

$FENC morons selling here

Analyst Ratings
HC Wainwright & Co. Buy Apr 4, 24
Craig-Hallum Buy Mar 18, 24
HC Wainwright & Co. Buy Aug 4, 23
HC Wainwright & Co. Buy Jun 21, 23
Cantor Fitzgerald Overweight Apr 6, 23
HC Wainwright & Co. Buy Apr 4, 23
HC Wainwright & Co. Buy Mar 31, 23
HC Wainwright & Co. Buy Jan 26, 23
Cantor Fitzgerald Overweight Nov 22, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Andrade Robert CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Jan 04 Sell 10.53 30,000 315,900 119,721 01/05/24
Raykov Rosty CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Dec 28 Sell 11.55 3,656 42,227 287,471 12/29/23
Raykov Rosty CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Dec 28 Option 1.59 8,540 13,579 291,127 12/29/23
RALLIS CHRIS A Director Director Dec 26 Sell 10.9 1,390 15,151 44,788 12/28/23
RALLIS CHRIS A Director Director Dec 26 Option 1.59 3,144 4,999 46,178 12/28/23
RALLIS CHRIS A Director Director Nov 20 Sell 8.25 269 2,219 43,034 11/20/23
Raykov Rosty CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Nov 03 Option 1.59 74,793 118,921 307,631 11/03/23
RALLIS CHRIS A Director Director Aug 18 Sell 7.85 673 5,283 43,303 08/18/23
RALLIS CHRIS A Director Director Jul 24 Sell 8.17 6,796 55,523 43,976 07/24/23
RALLIS CHRIS A Director Director Jul 24 Option 0.72 16,666 12,000 50,772 07/24/23
RALLIS CHRIS A Director Director Jul 06 Sell 8.47 2,207 18,693 28,826 07/06/23
RALLIS CHRIS A Director Director Jul 06 Option 0.96 5,280 5,069 34,106 07/06/23
Andrade Robert CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Jun 28 Sell 8.93 25,000 223,250 124,721 06/30/23
Andrade Robert CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Jun 28 Option 2.45 25,000 61,250 149,721 06/30/23
RALLIS CHRIS A Director Director Apr 17 Option 2.94 1,700 4,998 33,777 04/17/23
RALLIS CHRIS A Director Director Mar 03 Option 2.4 4,166 9,998 34,184 03/03/23
Raykov Rosty CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Dec 28 Sell 9.63 28,740 276,766 217,838 12/30/22
RALLIS CHRIS A Director Director Oct 20 Option 1.05 4,762 5,000 32,419 10/20/22
RALLIS CHRIS A Director Director Jul 18 Option 0.45 11,111 5,000 32,036 07/18/22
RALLIS CHRIS A Director Director Mar 08 Option 0.57 17,592 10,027 20,925 03/08/22